GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IRLAB Therapeutics AB (OSTO:IRLAB A) » Definitions » Pretax Margin %

IRLAB Therapeutics AB (OSTO:IRLAB A) Pretax Margin % : % (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is IRLAB Therapeutics AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. IRLAB Therapeutics AB's Pre-Tax Income for the three months ended in Mar. 2024 was kr-39.02 Mil. IRLAB Therapeutics AB's Revenue for the three months ended in Mar. 2024 was kr0.00 Mil. Therefore, IRLAB Therapeutics AB's pretax margin for the quarter that ended in Mar. 2024 was %.

The historical rank and industry rank for IRLAB Therapeutics AB's Pretax Margin % or its related term are showing as below:

OSTO:IRLAB A' s Pretax Margin % Range Over the Past 10 Years
Min: -411661.11   Med: -20874.89   Max: 24.92
Current: -2770.38


OSTO:IRLAB A's Pretax Margin % is ranked worse than
83.91% of 1019 companies
in the Biotechnology industry
Industry Median: -154.52 vs OSTO:IRLAB A: -2770.38

IRLAB Therapeutics AB Pretax Margin % Historical Data

The historical data trend for IRLAB Therapeutics AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IRLAB Therapeutics AB Pretax Margin % Chart

IRLAB Therapeutics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -369,692.31 - 24.92 -185.50 -3,132.07

IRLAB Therapeutics AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -653.64 - 2,934.98 -

Competitive Comparison of IRLAB Therapeutics AB's Pretax Margin %

For the Biotechnology subindustry, IRLAB Therapeutics AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IRLAB Therapeutics AB's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IRLAB Therapeutics AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where IRLAB Therapeutics AB's Pretax Margin % falls into.



IRLAB Therapeutics AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

IRLAB Therapeutics AB's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-177.839/5.678
=-3,132.07 %

IRLAB Therapeutics AB's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-39.019/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IRLAB Therapeutics AB  (OSTO:IRLAB A) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


IRLAB Therapeutics AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of IRLAB Therapeutics AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


IRLAB Therapeutics AB (OSTO:IRLAB A) Business Description

Traded in Other Exchanges
Address
Arvid Wallgren Backe 20, Goteborg, SWE, 413 46
IRLAB Therapeutics AB is a drug discovery and development company providing novel treatments for disorders of the brain. The company focuses on innovative treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in the clinical development of novel compounds which aims at offering improved clinical benefit for patients with Parkinson's disease. The company's current clinical candidates, mesdopetam (IRL790) and pirepemat (IRL752), both of which have successfully gone through Phase I safety and Phase IIa efficacy proof-of-concept studies, are now in Phase IIb trials.

IRLAB Therapeutics AB (OSTO:IRLAB A) Headlines

No Headlines